The question of whether it is necessary to receive the pentavalent vaccine should be considered based on the baby's physical condition. If the child's physical condition is good, taking sugar pills is enough, and there is no need to receive the pentavalent vaccine. It is not necessarily good just because it is expensive. But the biggest advantage of the pentavalent vaccine is getting 8 fewer doses, and parents can consider whether to get vaccinated based on their family situation.
The pentavalent vaccine has undergone 12 clinical trials in 9 countries using 5 different vaccination procedures, and the research results have confirmed that the pentavalent vaccine for children is a safe and effective vaccine. Compared with receiving polio, pertussis, and Hib vaccines separately, receiving the pentavalent vaccine for children is equally safe and effective.
After receiving the vaccine, children may have adverse reactions, which are usually more obvious during the second dose. Parents should pay attention to observation. The main adverse reactions include local redness and swelling, fever, pain, fatigue, and itching. Most children's fever is transient and can recover on its own with plenty of water, while a few children with fever need to use antipyretic and analgesic drugs; Local redness and swelling can be treated with hot compress.
1. Caution should be exercised when used for individuals with thrombocytopenia and coagulation disorders (as there may be a risk of bleeding after intramuscular injection).
2. If there have been non febrile seizures unrelated to the previous vaccine injection, caution should be exercised when considering administering the pentavalent vaccine.
3. If any of the following situations occur, which may temporarily be related to vaccination, caution should be exercised when deciding whether to further administer vaccines containing pertussis: fever of ≥ 40 ℃ that occurs within 48 hours and is not caused by other clear reasons; Symptoms of collapse or shock within 48 hours after vaccination; Within 48 hours after vaccination, crying that lasts for more than 3 hours and cannot be calmed down; Seizures with or without fever within 3 days after vaccination.
4. If receiving immunosuppressive therapy or suffering from immunodeficiency; In this case, the body may reduce its immune response to the vaccine. Therefore, it is recommended to receive vaccination after the treatment is completed.
5. When administering basic immunization to premature infants born at ≤ 28 weeks of gestation, potential risk of asphyxia should be considered and necessary 48-72 hour respiratory monitoring should be conducted, especially for infants with a history of respiratory system underdevelopment.
6. When the baby suffers from acute infectious diseases, such as colds, diarrhea, etc., uses immunosuppressants, such as hormones, and has congenital heart disease, severe liver and kidney disease, severe eczema, and congenital immune deficiency, do not take risks to vaccinate the baby. Most serious consequences occur in these circumstances.
7. Before vaccination, parents should understand the variety, function, contraindications, adverse reactions, precautions, cost sharing, compensation methods for abnormal reactions, etc. of the vaccine, and truthfully provide medical staff with the child's health status and vaccination contraindications.
8. After vaccination, children should observe the vaccination site for 30 minutes and leave only after there are no special circumstances. Individual children may experience transient fever, redness, swelling, hardening, pain, and other reactions at the vaccination site after vaccination, which generally do not require special treatment and can be relieved on their own. If adverse reactions listed in the vaccine instructions occur, it is necessary to seek medical treatment promptly and inform the vaccination unit of the reported situation.
Not every child is suitable for receiving the pentavalent vaccine. Individuals allergic to the vaccine and any of its components, including excipients, antibiotics, and other serious adverse reactions; Individuals with acute diseases, severe chronic diseases, acute exacerbations of chronic diseases, and fever; Individuals with brain diseases, uncontrolled epilepsy, and other progressive neurological disorders; Individuals who experience neurological reactions after receiving pertussis, diphtheria, and tetanus vaccines cannot receive the pentavalent vaccine.
